首页 | 本学科首页   官方微博 | 高级检索  
     

小剂量奥曲肽用于肝硬化顽固性腹水疗效观察
引用本文:龚梅金,卢卫. 小剂量奥曲肽用于肝硬化顽固性腹水疗效观察[J]. 中国医药导报, 2011, 8(36): 78-79
作者姓名:龚梅金  卢卫
作者单位:1. 深圳市南山区西丽人民医院消化内科,广东深圳,518055
2. 深圳市第六人民医院,广东深圳,518053
摘    要:目的:探讨小剂量奥曲肽对肝硬化顽固性腹水的治疗效果。方法:选择我院2007年1月~2010年12月间收治的65例肝硬化顽固性腹水患者,根据治疗方法的不同将其分为两组,对照组30例患者行保肝、限制钠盐和水、补充白蛋白及使用利尿剂等常规治疗,观察组35例患者在对照组治疗的基础上加用奥曲肽,治疗14 d后比较两组临床疗效。结果:观察组治疗总有效率为88.6%,明显高于对照组56.7%的治疗有效率,且尿量及腹水减少量明显高于对照组,门脉压力较对照组明显降低,两组比较差异有统计学意义(P〈0.05)。结论:小剂量奥曲肽是一种较为理想地消除肝硬化顽固性腹水的治疗方法。

关 键 词:奥曲肽  小剂量  肝硬化顽固性腹水  疗效

The effect observation of low -dose Octreotide in the treatment of cirrhosis with refractory ascites
GONG Meijin,LU Wei. The effect observation of low -dose Octreotide in the treatment of cirrhosis with refractory ascites[J]. China Medical Herald, 2011, 8(36): 78-79
Authors:GONG Meijin  LU Wei
Affiliation:GONG Meijin1,LU Wei2 1.Department of Digestive System,Xili People's Hospital of Nanshan District in Shenzhen City,Guangdong Province,Shenzhen 518055,China,2.The 6th People's Hospital of Shenzhen City,Shenzhen 518053
Abstract:Objective:To explore the treatment effect of low-dose Octreotide for cirrhosis with refractory ascites.Methods:65 patients of cirrhosis with refractory ascites admitted to our hospital from January 2007 to December 2010 were randomly divided into two groups according to different methods of treatment.30 patients in the control group were given the conventional treatment of protecting liver,limiting sodium and water,supplying albumin and using diuretics and so on,on the basis of control group,35 patients of ...
Keywords:Octreotide  Low-dose  Cirrhosis with refractory ascites  Effect  
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号